{"id":"W4387357326","doi":"10.3324/haematol.2023.283303","title":"Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1","year":2023,"lang":"en","type":"letter","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Seagen","keywords":"Brentuximab vedotin; Classical Hodgkin lymphoma; Chemotherapy; Medicine; Stage (stratigraphy); Hodgkin lymphoma; Oncology; Internal medicine; Lymphoma; Pediatrics; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003529911,0.0003138399,0.0004585736,0.0003739313,0.001339255,0.0007993147,0.0005185144,0.004945113,0.002874814],"category_scores_gemma":[0.002804683,0.0003171406,0.000518321,0.0003161619,0.000602664,0.0008568905,0.0004204217,0.003961089,0.0006634235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00153096,"about_ca_system_score_gemma":0.001131268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004727683,"about_ca_topic_score_gemma":0.01358667,"domain_scores_codex":[0.9996518,0.0000976449,0.00004706321,0.00003885235,0.00005391425,0.0001108268],"domain_scores_gemma":[0.9990514,0.0003713572,0.0001175017,0.00002186835,0.00005982631,0.0003779895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006778596,0.0004689453,0.1150885,0.0002248748,0.00009294043,0.7167567,0.0005484277,0.0006377285,0.001574519,0.003173071,0.1274703,0.03328609],"study_design_scores_gemma":[0.0005830324,0.001135849,0.09306864,0.0008411491,0.0001833659,0.7508183,0.001297562,0.002928864,0.001182768,0.005279835,0.1426256,0.00005508337],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.3336589,0.02524471,0.001008041,0.5321506,0.01225915,0.0001769734,0.0003761365,0.0001596768,0.0949658],"genre_scores_gemma":[0.8284538,0.007561596,0.0009805043,0.1309062,0.01524085,0.00007121347,0.0002007017,0.0000543338,0.01653073],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.004945113,"threshold_uncertainty_score":0.01110792,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01932127148719474,"score_gpt":0.2560877336693754,"score_spread":0.2367664621821807,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}